NCT03331302View on ClinicalTrials.gov

Hyper Polarized Xenon-129 MRI vs Xenon-133 Scintigraphy

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

June 30, 2020

Study Completion Date

December 31, 2020

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Hyperpolarized Xenon-129 MRI (Experimental)

MRI ventilation scan of the lung with inhaled contrast agent (hyperpolarized Xenon-129)

DRUG

Radioactive Xenon-133 scintigraphy (Active Comparator)

Radioactive ventilation scintigraphy of the lung with inhaled radioactive contrast agent (Xenon-133)

Trial Locations (1)

22908

RECRUITING

University of Virginia Health System, Charlottesville

All Listed Sponsors
lead

University of Virginia

OTHER